Karyopharm Therapeutics reported $27.45M in Trade Debtors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Amgen AMGN:US USD 5.56B 237M
Astrazeneca AZN:US USD 10.06B 449M
AstraZeneca AZN:LN USD 10.06B 449M
Avrobio Inc AVRO:US USD 2.98M 24K
Biocryst Pharmaceuticals BCRX:US USD 42.61M 1.12M
Bristol Myers Squibb BMY:US USD 13.24B 700M
Eli Lilly And LLY:US USD 8.32B 652.4M
Enanta Pharmaceuticals ENTA:US USD 49.04M 829K
GlaxoSmithKline GSK:LN GBP 7.46B 636M
Karyopharm Therapeutics KPTI:US USD 27.45M 3.97M
Macrogenics MGNX:US USD 13.84M 4.55M
Merk MRK:US USD 9.48B 161M
Mirati Therapeutics MRTX:US USD 1.68M 153K
Nektar Therapeutics NKTR:US USD 11.53M 1.53M
Novartis NVS:US USD 8.33B 346M
Novartis NOVN:VX USD 8.68B 230M
Regeneron Pharmaceuticals REGN:US USD 5.55B 386.9M
Roche Holding ROG:VX 11.08B 48M
Sangamo Biosciences SGMO:US USD 5.05M 1.24M
Takeda 4502:JP JPY 779.87B 20.66B
Ultragenyx Pharmaceutical RARE:US USD 31.16M 6.04M
Xencor XNCR:US USD 44.88M 9.41M
YTE INCY:US USD 618.19M 64.78M